Immunicum: Q2 report and a New CEO

Research Note

2020-08-28

10:48

Redeye views the appointment of a permanent CEO as an important step to improve sentiment around the shares as well as facilitate the implementation of corporate strategy. Moreover, the new CEO seems like a good fit with Immunicum’s current focus, we believe.

NE

Niklas Elmhammer

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.